Long-term use of a nasal expiratory positive airway pressure (EPAP) device as a treatment for obstructive sleep apnea (OSA)

Journal of Clinical Sleep Medicine

Volumn 7, Issue 5, 2011, Pages 449-453

  Kryger, Meir H ^a   Berry, Richard B ^b   Massie, Clifford A ^c  

^a Gaylord Hospital Wallingford   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c Chicago Sleep Group of Suburban Lung Associates   (United States)

Author keywords

CPAP; Expiratory positive airway pressure; Obstructive sleep apnea

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEVICE SAFETY; EPWORTH SLEEPINESS SCALE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME; SLEEP TIME; SNORING; TREATMENT RESPONSE;

COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POLYSOMNOGRAPHY; POSITIVE-PRESSURE RESPIRATION; PROSPECTIVE STUDIES; SLEEP APNEA, OBSTRUCTIVE; TIME; TREATMENT OUTCOME;

EID: 80054722878     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/JCSM.1304     Document Type: Article

References (12)

1. Young T, Palta M, Dempsey J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993; 328:1230-5. (Pubitemid 23115702)
2. Epstein LJ, Kristo D, Strollo P, et al. Clinical guideline for the evaluation, management, and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009;5:263-76.
3. Marin JM, Carrizo SJ, Vicente E, Augusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53. (Pubitemid 40386782)
4. Colrain IM, Brooks S, Black J. A pilot evaluation of a nasal expiratory resistance device for the treatment of obstructive sleep apnea. J Clin Sleep Med 2008;4:426-33.
5. Rosenthal L, Massie CA, Dolan DC, Loomas B, Kram J, Hart RW. A multicenter, prospective study of a novel nasal EPAP device in the treatment of obstructive sleep apnea: efficacy and 30-day adherence. J Clin Sleep Med 2009;5:532-7.
6. Walsh JK, Griffin KS, Schweitzer PK, et al. A convenient expiratory positive airway pressure nasal device for the treatment of sleep apnea in patients non-adherent with continuous positive airway pressure. Sleep Med 2011:12:147-52
7. Patel AV, Hwang D, Rapoport DM, et al. Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea (OSA). J Clin Sleep Med 2011:7:13-22
8. Berry RB, Kryger MH, Massie CA. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial. Sleep 2011;34:479-85
9. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
10. Iber C, Ancoli-Israel S, Chesson A, Quan SF for the American Academy of Sleep Medicine. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st ed. Westchester, IL: American Academy of Sleep Medicine, 2007.
11. Weaver TE, Grunstein RR. Adherence to continuous positive airway pressure therapy: the challenge to effective treatment. Proc Am Thorac Soc 2008;15:173-8. (Pubitemid 351237875)
12. Wolkove N, Baltzan M, Kamel H, Dabrusin R, Palayew M. Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Can Respir J 2008;15:365-9.